Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 29, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

Cell-based therapy for neural disorders--anticipating challenges.

Arlene Y Chiu1, Mahendra S Rao

  • 1Beckman Research Institute of the City of Hope, Duarte, CA, USA. achiu@coh.org

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|September 9, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xenogeneic-free defined conditions for derivation and expansion of human embryonic stem cells with mesenchymal stem cells.

Regenerative therapy·2019
Same author

The Future State of Newborn Stem Cell Banking.

Journal of clinical medicine·2019
Same author

INDEX-db: The Indian Exome Reference Database (Phase I).

Journal of computational biology : a journal of computational molecular cell biology·2019
Same author

Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.

Stem cells (Dayton, Ohio)·2018
Same author

Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.

Cytotherapy·2018
Same author

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.

Frontiers in medicine·2018
Same journal

FGF17 synergistically targets neuronal survival and oligodendrogenesis to restore stroke deficits.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Neurological complications of current and emerging CAR-T cell therapies.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Hemodynamics Beyond Ischemic Zone Underlies Early Neurological Deterioration in Minor Stroke with Large Vessel Occlusion.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Nervonic acid and the long arc of therapeutic hope in X-linked adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Long-term efficacy of subthalamic nucleus deep brain stimulation in focal motor seizures and implications for candidate selection.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
See all related articles

Cell-based therapies offer hope for neurological diseases like Alzheimer's and Parkinson's, showing promise in preclinical and early human trials. Addressing unique challenges in nervous system repair is key to advancing these treatments.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Neurological diseases cause progressive cognitive and physical decline, with limited treatment options.
  • Cell-based interventions are being explored as alternative treatments for nervous system disorders.
  • Pluripotent stem cells can differentiate into neural cells, fueling research in cell-based therapies.

Purpose of the Study:

  • To review the challenges and potential of cell replacement therapies for neurological conditions.
  • To highlight the need for careful planning in developing cell-based interventions for the human nervous system.

Main Methods:

  • Review of current research on cell-based interventions for neurological diseases.
  • Analysis of challenges in cell therapy development, manufacturing, delivery, and monitoring.

More Related Videos

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

GM-Free Generation of Blood-Derived Neuronal Cells
08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

Related Experiment Videos

Last Updated: May 29, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

GM-Free Generation of Blood-Derived Neuronal Cells
08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

  • Discussion of the unique demands of the central and peripheral nervous systems.
  • Main Results:

    • Successful demonstrations of cell types in animal models for neurological conditions.
    • Early-stage human clinical trials showing some degree of success.
    • Identification of key challenges in cell therapy for neurological disorders, including cell choice, manufacturing, delivery, and patient monitoring.

    Conclusions:

    • Cell replacement therapies hold significant potential for treating devastating neurological diseases.
    • Overcoming challenges related to the nervous system's complexity is crucial for successful clinical translation.
    • Careful planning and attention to the nervous system's specific demands are essential for advancing cell-based treatments.